A cardioprotective approach to the management of hypertension

Journal of Hypertension, Supplement

Volumn 18, Issue 3, 2000, Pages

  Kaplan, N M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Guidelines; Hypertension therapy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ANTIHYPERTENSIVE ACTIVITY; CARDIOVASCULAR RISK; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CORONARY DISEASE; HUMANS; HYPERTENSION;

EID: 0033837921     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2. 1999 Wodd Health Organization-International Society of Hypertension guidelines for the management of hypertension
3. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
4. Randomised trial of old and new antihypertensive drugs in eldedy patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 Study
5. The Heart Outcomes Prevention Evaluation Study Investigators Effect of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
6. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
7. Treatment of hypertension: Drug therapy